# 4056
From Mike Stobbe, medical writer for the AP, we get this news report about 4 people in North Carolina who have tested positive for a Tamiflu resistant strain of the H1N1 virus.
First the story and then a few comments about reports of mutations and such.
I’ve just printed a small excerpt, follow the link to read the full story.
Associated Press
Tamiflu-resistant swine flu cluster reported in NC
By MIKE STOBBE , 11.20.09, 03:43 PM EST
ATLANTA -- Four North Carolina patients at a single hospital tested positive for a type of swine flu that is resistant to Tamiflu, health officials said Friday. The cases reported at Duke University Medical Center over six weeks make up the biggest cluster seen so far in the U.S.
<SNIP>
The CDC has sent three disease investigators to North Carolina to help in the investigation there, said Dave Daigle, a CDC spokesman. CDC testing confirmed the Tamiflu-resistant cases.
All four cases at the hospital were very ill patients in an isolated cancer unit on the hospital's ninth floor, and it is believed they all caught the flu while at the hospital, said Dr. Daniel Sexton, professor of medicine and director of the Duke Infection Control Outreach Network.
Today we’ve had a flurry of reports on Tamiflu resistant H1N1 strains and genetic mutations.
I’ve no doubt that there will be some websites, blogs, and tabloid news sources that will report these stories in breathless sky-is-falling fashion, looking to eek out the maximum mileage from these reports.
That’s how a large part of the media – new, traditional, or otherwise – functions. It’s all about driving traffic.
But after 4 years of blogging about emerging infectious diseases, I can assure you the sky very rarely really falls.
These stories are, obviously, of scientific importance. And they deserve to be reported, and discussed.
But right now there is very little evidence that any of these reports are any sort of `game changers’ for this pandemic, or that they currently constitute a broader public health threat.
Could they be?
Yes, it’s possible. And maybe that evidence will come later. But for now, these appear to be relatively isolated incidents.
Since seasonal H1N1 picked up nearly universal Tamiflu resistance in just over a year’s time, many scientists are watching reports of resistant samples warily. No one would be terribly surprised to see increasing levels of resistant swine flu viruses being detected.
The vast majority of H1N1 cases continue to respond to the Tamiflu antiviral, and for those few that don’t, Relenza remains effective.
As we move deeper into fall and winter, these types of stories are likely to come at us fast and furiously from all different directions. While some of them may portend important changes in the pandemic, many will not.
Often, the only way you can tell one kind from the other is to give these stories some time to develop.
Related Post:
- ECDC: Multidrug Resistant Infections Increasing In Europe
- A Health Crisis In Slow Motion
- Referral: McKenna On Resistant Gonorrhea
- EID: Environmental NDM-1 Detected In Vietnam
- Referral: McKenna On Resistant UTIs
- MMWR: NDM-1 Transmission In Rhode Island
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- WHO: Urgent Action Needed On Resistant Gonorrhea
- CDC Grand Rounds: Multidrug-Resistant Gonorrhea
- Video: Maryn McKenna On Antibiotic Resistance
- Indonesia: MOH Suspects H5N1 May Be Gaining Antiviral Resistance
- NPR Science Friday: McKenna On Resistant TB
- ECDC Comment On Drug Resistant TB In India
- NEJM: Oseltamivir Resistant H1N1 in Australia
- CIDRAP News: Signs Of Tamiflu Resistant H1N1 Spreading
- WER: Update On Anti-Viral Resistant Influenza
- CDDEP: Mapping Resistance
- ECDC: Risk Assessment On Australia’s Antiviral Resistant H1N1 Cluster
- Australia Reports Cluster Of Antiviral Resistant H1N1
- NDM-1: One Year Later
- The Global Spread Of Drug Resistant Salmonella
- Netherlands: Large Nosocomial KPC Outbreak
- IDSA: Educational Guidelines Lower Antibiotic Use
- Going, Going, Gonorrhea
- Declan Butler On Growing Mosquito Insecticide Resistance
- Canada Releases Tamiflu From National Emergency Stockpile
- Study: The Benefits Of Antiviral Therapy During the 2009 Pandemic
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- The CDC Responds To The Cochrane Group’s Tamiflu Study
- The Tamiflu Controversy Continues
- NEJM: Oseltamivir Resistant H1N1 in Australia
- CIDRAP News: Signs Of Tamiflu Resistant H1N1 Spreading
- Australia Reports Cluster Of Antiviral Resistant H1N1
- The WHO’s Flu Review
- CIDRAP: UK Findings Hint At Resistant Flu Strain
- Study: Oseltamivir-Resistant Pandemic Flu Cases In The US
- PLoS Medicine: Mono or Combo Antiviral Therapy?
- BMJ: Efficacy of Oseltamivir In Mild H1N1
- Study: Antiviral Therapy For H5N1
- Fitness Of Oseltamivir-Resistant A/H1N1/2009
- FDA Warns On Fake Tamiflu
- Study: Oseltamivir Treatment of Infants Under One Year
- Caltech: How Seasonal Flu Gained Tamiflu Resistance
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- NIH: Rapid Development Of Antiviral Resistance In Two Cases
- The Path Of Increased Resistance
- UK: National Pandemic Flu Service Stands Down
- WER Review: Oseltamivir Resistance In Pandemic H1N1
- South Korea Reports A Tamiflu-Resistant H1N1 Fatality
- Referral: Effect Measure On The BMJ Tamiflu Story
Widget by [ Iptek-4u ]